聚乳酸切片
Search documents
惠通科技:全资子公司惠通生物的聚乳酸切片目前仅完成首次投料试车
Zheng Quan Ri Bao Wang· 2025-12-18 11:12
Group 1 - The company, Huitong Technology (301601), is a provider of production equipment and engineering contracting services for biodegradable materials [1] - The company's subsidiary, Huitong Bio, has completed the initial trial run of polylactic acid (PLA) chips, which is currently in the problem review and optimization phase [1]
惠通科技:全资子公司惠通生物的聚乳酸切片目前仅完成首次投料试车,还处于问题复盘和整改优化阶段
Mei Ri Jing Ji Xin Wen· 2025-12-18 09:57
Group 1 - The company, Huitong Technology (301601.SZ), is involved in the production of biodegradable materials and provides engineering contracting services for related equipment [2] - The company's subsidiary, Huitong Bio, has completed the initial trial run of polylactic acid (PLA) chips, which is currently in the problem review and optimization phase [2] - The company acknowledges that its downstream clients are directly involved in the production of biodegradable films, indicating a connection to new agricultural practices and rural revitalization [2]
惠通科技:年产3万吨聚乳酸切片装置首次投料试车
Xin Lang Cai Jing· 2025-12-16 04:06
转自:智通财经 【惠通科技:年产3万吨聚乳酸切片装置首次投料试车】智通财经12月16日电,据惠通科技消息,12 月,扬州惠通生物新材料有限公司年产3万吨聚乳酸切片装置进行了首次投料试车,此次试车采用惠通 科技自主研发的丙交酯生产工艺及关键设备以及苏尔寿提纯与聚合关键设备及技术,实现了工艺全流程 贯通。 ...
惠通科技:年产3万吨聚乳酸切片装置首次投料试车达成阶段性目标
Zheng Quan Shi Bao Wang· 2025-12-16 02:57
人民财讯12月16日电,据惠通科技(301601)消息,12月,扬州惠通生物新材料有限公司年产3万吨聚 乳酸切片装置进行了首次投料试车,此次试车采用惠通科技自主研发的丙交酯生产工艺及关键设备以及 苏尔寿提纯与聚合关键设备及技术,实现了工艺全流程贯通。此次投料试车取得了阶段性成果,公司将 以此为契机,继续深耕差别化聚乳酸切片领域,聚焦高附加值纺织应用、高端医疗应用、3D打印等细 分市场需求。 ...